Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

darbepoetin alfa

darbepoetin alfa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Aranesp SOLUTION, INJECTABLE 25 mcg/mL, 40 mcg/mL, 60 mcg/mL    
Aranesp SOLUTION, INJECTABLE 100 mcg/mL, 200 mcg/mL, 300 mcg/mL    
Aranesp SOLUTION, INJECTABLE 500 mcg/mL    
VIEW MORE Hematopoietic Agents
CLASS
201600
Comments:

Aranesp Medication Guide

Aranesp is converted to Procrit. See Erythropoietin Formulary for dose conversions.

Reviewed: December 12, 2006

 

Last updated: Nov. 20, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved